Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Pulse Biosciences, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Price | Fee Rate | Amount of Registration Fee | |||||||||
| Fees to Be Paid | Equity | Common Stock, par value $0.001 per share | 457(o) | (1) | (1) | (1) | ||||||||||
| Unallocated (Universal) Shelf | Unallocated (Universal) Shelf | 457(o) | (1) | (1) | $10,000,000 | 0.00014760 | $1,476 | |||||||||
| Fees Previously Paid | — | — | — | — | — | — | — | |||||||||
| Total Offering Amounts | $10,000,000 | $1,476 | ||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||
| Total Fee Offsets | — | |||||||||||||||
| Net Fee Due | $1,476 | |||||||||||||||
| (1) | The Registrant previously registered the offer and sale of certain securities, including its common stock, par value $0.001 per share, having a proposed maximum aggregate offering price of $50,000,000 pursuant to Registration Statement on Form S-3 (File No. 333-278322), which was filed on March 28, 2024 and declared effective by the SEC on April 8, 2024 (the “Prior Registration Statement”). As of the date hereof, a balance of $50,000,000 of such securities remains unsold under the Prior Registration Statement. In accordance with Rule 462(b) under the Securities Act of 1933, as amended, and General Instruction IV(A) of Form S-3, the Registrant is hereby registering the offer and sale of an additional $10,000,000 of its shares of common stock. The additional amount of securities that is being registered for offer and sale represents no more than 20% of the maximum aggregate offering price of the remaining securities available to be sold under the Prior Registration Statement. |
